Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2008 1
2009 1
2011 2
2012 4
2013 7
2014 4
2015 3
2016 5
2017 7
2018 4
2019 4
2020 7
2021 9
2022 6
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
Jabbari E, Holland N, Chelban V, Jones PS, Lamb R, Rawlinson C, Guo T, Costantini AA, Tan MMX, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, Holton JL, Revesz T, Warner TT, Lees AJ, Zetterberg H, Russell LL, Bocchetta M, Rohrer JD, Williams NM, Grosset DG, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu MTM, Woodside J, Houlden H, Rowe JB, Morris HR. Jabbari E, et al. JAMA Neurol. 2020 Mar 1;77(3):377-387. doi: 10.1001/jamaneurol.2019.4347. JAMA Neurol. 2020. PMID: 31860007 Free PMC article.
IMPORTANCE: Atypical parkinsonian syndromes (APS), including progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and multiple system atrophy (MSA), may be difficult to distinguish in early stages and are often misdiagnosed as Parkinson d …
IMPORTANCE: Atypical parkinsonian syndromes (APS), including progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), and …
Parkinsonism.
Keener AM, Bordelon YM. Keener AM, et al. Semin Neurol. 2016 Aug;36(4):330-4. doi: 10.1055/s-0036-1585097. Epub 2016 Sep 19. Semin Neurol. 2016. PMID: 27643900 Review.
Idiopathic Parkinson disease (PD) is the most common cause of this syndrome, though there are several other important etiologies that must be considered. These include the atypical Parkinsonian disorders multiple system atrophy (MSA), dementia with Lewy Bodie …
Idiopathic Parkinson disease (PD) is the most common cause of this syndrome, though there are several other important etiologies that must b …
Progression of atypical parkinsonian syndromes: PROSPECT-M-UK study implications for clinical trials.
Street D, Jabbari E, Costantini A, Jones PS, Holland N, Rittman T, Jensen MT, Chelban V, Goh YY, Guo T, Heslegrave AJ, Roncaroli F, Klein JC, Ansorge O, Allinson KSJ, Jaunmuktane Z, Revesz T, Warner TT, Lees AJ, Zetterberg H, Russell LL, Bocchetta M, Rohrer JD, Burn DJ, Pavese N, Gerhard A, Kobylecki C, Leigh PN, Church A, Hu MTM, Houlden H, Morris H, Rowe JB. Street D, et al. Brain. 2023 Aug 1;146(8):3232-3242. doi: 10.1093/brain/awad105. Brain. 2023. PMID: 36975168 Free PMC article.
Here we report the longitudinal PROSPECT-M-UK study of progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple system atrophy (MSA) and related disorders, to compare candidate clinical trial end points. ...One hundred and fifty-nine …
Here we report the longitudinal PROSPECT-M-UK study of progressive supranuclear palsy (PSP), corticobasal syndrome (CBS), multiple …
Blood based biomarkers for movement disorders.
Morris HR. Morris HR. Acta Neurol Scand. 2022 Oct;146(4):353-361. doi: 10.1111/ane.13700. Acta Neurol Scand. 2022. PMID: 36156206 Free PMC article. Review.
Serum or plasma neurofilament light (NfL) may be useful in separating Parkinson's plus syndromes (progressive supranuclear palsy-PSP, multiple system atrophy - MSA, and corticobasal syndrome-CBS) from PD. ...
Serum or plasma neurofilament light (NfL) may be useful in separating Parkinson's plus syndromes (progressive supranuclear palsy-PSP, mul …
Planimetric and Volumetric Brainstem MRI Markers in Progressive Supranuclear Palsy, Multiple System Atrophy, and Corticobasal Syndrome. A Systematic Review and Meta-Analysis.
Brinia ME, Kapsali I, Giagkou N, Constantinides VC. Brinia ME, et al. Neurol Int. 2023 Dec 19;16(1):1-19. doi: 10.3390/neurolint16010001. Neurol Int. 2023. PMID: 38392951 Free PMC article. Review.
BACKGROUND: Various MRI markers-including midbrain and pons areas (M(area), P(area)) and volumes (M(vol), P(vol)), ratios (M/P(area), M/P(vol)), and composite markers (magnetic resonance imaging Parkinsonism Indices 1,2; MRPI 1,2)-have been proposed as imaging markers of Richards …
BACKGROUND: Various MRI markers-including midbrain and pons areas (M(area), P(area)) and volumes (M(vol), P(vol)), ratios (M/P(area), M/P(vo …
Evaluation of α-synuclein in CNS-originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta-analysis.
Taha HB, Ati SS. Taha HB, et al. CNS Neurosci Ther. 2023 Dec;29(12):3741-3755. doi: 10.1111/cns.14341. Epub 2023 Jul 7. CNS Neurosci Ther. 2023. PMID: 37416941 Free PMC article. Review.
BACKGROUND & AIMS: Parkinsonian disorders, such as Parkinson's disease (PD), multiple system atrophy (MSA), dementia with Lewy bodies (DLB), progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS), share early motor symptoms but have d …
BACKGROUND & AIMS: Parkinsonian disorders, such as Parkinson's disease (PD), multiple system atrophy (MSA), dementi …
Cerebrospinal fluid and blood serum biomarkers in neurodegenerative proteinopathies: A prospective, open, cross-correlation study.
Koníčková D, Menšíková K, Klíčová K, Chudáčková M, Kaiserová M, Přikrylová H, Otruba P, Nevrlý M, Hluštík P, Hényková E, Kaleta M, Friedecký D, Matěj R, Strnad M, Novák O, Plíhalová L, Rosales R, Colosimo C, Kaňovský P. Koníčková D, et al. J Neurochem. 2023 Oct;167(2):168-182. doi: 10.1111/jnc.15944. Epub 2023 Sep 7. J Neurochem. 2023. PMID: 37680022
Neurodegenerative diseases are a broad heterogeneous group affecting the nervous system. They are characterized, from a pathophysiological perspective, by the selective involvement of a subpopulation of nerve cells with a consequent clinical picture of a disease. ...In thi …
Neurodegenerative diseases are a broad heterogeneous group affecting the nervous system. They are characterized, from a pathophysiolo …
Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease.
Paslawski W, Khosousi S, Hertz E, Markaki I, Boxer A, Svenningsson P. Paslawski W, et al. Transl Neurodegener. 2023 Sep 4;12(1):42. doi: 10.1186/s40035-023-00374-w. Transl Neurodegener. 2023. PMID: 37667404 Free PMC article.
Using a large-scale multiplex proximity extension assay (PEA) approach, we aimed to discover novel diagnostic protein biomarkers allowing accurate discrimination of PD from both controls and atypical Parkinsonian disorders (APD). METHODS: CSF from patients with PD, corticobasal s …
Using a large-scale multiplex proximity extension assay (PEA) approach, we aimed to discover novel diagnostic protein biomarkers allowing ac …
Markedly asymmetric presentation in multiple system atrophy.
Batla A, Stamelou M, Mensikova K, Kaiserova M, Tuckova L, Kanovsky P, Quinn N, Bhatia KP. Batla A, et al. Parkinsonism Relat Disord. 2013 Oct;19(10):901-5. doi: 10.1016/j.parkreldis.2013.05.004. Epub 2013 Jun 6. Parkinsonism Relat Disord. 2013. PMID: 23746453
BACKGROUND: Multiple system atrophy (MSA) presents with fairly symmetrical, levodopa unresponsive parkinsonism and additional features like autonomic dysfunction, cerebellar and corticospinal tract involvement. ...CONCLUSIONS: We use these cases to highlight …
BACKGROUND: Multiple system atrophy (MSA) presents with fairly symmetrical, levodopa unresponsive parkinsonism and addi …
Overview of sleep disturbances and their management in Parkinson plus disorders.
Bhattacharya A, Lenka A, Stezin A, Kamble N, Pal PK. Bhattacharya A, et al. J Neurol Sci. 2020 Aug 15;415:116891. doi: 10.1016/j.jns.2020.116891. Epub 2020 May 8. J Neurol Sci. 2020. PMID: 32446010 Review.
Sleep disturbance is one of the commonly reported non-motor symptoms in patients with Parkinson's disease (PD) as well as in Parkinson plus disorders such as multiple system atrophy (MSA), dementia with Lewy bodies (DLB), progressive supranuclear palsy (PSP), …
Sleep disturbance is one of the commonly reported non-motor symptoms in patients with Parkinson's disease (PD) as well as in Parkinson plus …
70 results